Jeremy Agresti’s pioneering work in microfluidics has transformed the pace of biology. Over his groundbreaking career, he’s amassed over 9,000 citations across several seminal papers.
Learn how Jeremy’s work has become the foundation for several companies in the field including Amyris, Bio-Rad and 10x Genomics.
Jeremy is a co-founder and advisor at Slingshot Biosciences and the founder and CTO of Triplebar, where his team harnesses the power of evolution to create sustainable, biology-produced products for a brighter future.
This episode is a must-listen for anyone passionate about the future of biology and the possibilities it holds.